Related posts
Most Anticipated Earnings: GSP-X, ESK-X and more Canadian Companies Reporting Earnings this Week (Mar 31-Apr 01)U.S. data sinks stocksQuiet TuesdayThis summary was created by AI, based on 9 opinions in the last 12 months.
Loblaw Companies Ltd is viewed positively by experts, highlighting its solid performance in the challenging grocery sector, marked by low margins and intense competition. Analysts appreciate the company's transformation following its acquisition of Shoppers Drug Mart, which has provided significant growth opportunities, especially in the pharmacy and healthcare realms. With the changing consumer behavior, particularly towards discount banners, Loblaw is well-positioned to capitalize on the evolving market dynamics. Despite its successes, there are concerns regarding rising tariffs that may impact consumers negatively and potentially lead to job losses. Many recommend waiting for a pullback before making new investments but suggest that existing shareholders should hold their positions due to the company's long-term prospects.
Wait for a pullback, given current highs. As Canada's economy softens, more shoppers spend at their discount banners. Shoppers are doing very well in beauty goods as they get out of the low-margin electronics; many provinces are allowing pharmacists to expand their role, which is another tailwind for Shoppers Drug Mart (that Loblaw owns). They are expanding their margins and guiding higher.
Remarkable sprint for a grocer and drugstore, executing well on both. Benefited from discount banners. Higher margins on strong private label portfolio. SDM is doing very well, same-store sales going up, pharmacies expanding scope of service -- increases revenue and foot traffic. Wait for a pullback to enter.
Defensive consumer staple going into economic slowdown. Over half of food banners are in discount, seeing increased traffic. Plus, more people are cooking at home rather than eating out. SDM has great locations, offers Loblaw products; pharmacists expanding roles, and this increases general traffic. Yield is 1.45%.
(Analysts’ price target is $135.40)Very few competitors, and those types of names tend to perform well long-term. Largest grocery retailer, so procures good prices and controls distribution. Shoppers Drug Mart provide lots of earnings. Loyalty programs doing well. As a consumer staple, won't participate with more cyclical names. Defensive part of your portfolio. If you're up nicely, you could take some profits.
Loblaw Companies Ltd is a Canadian stock, trading under the symbol L-T on the Toronto Stock Exchange (L-CT). It is usually referred to as TSX:L or L-T
In the last year, 13 stock analysts published opinions about L-T. 3 analysts recommended to BUY the stock. 5 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Loblaw Companies Ltd.
Loblaw Companies Ltd was recommended as a Top Pick by on . Read the latest stock experts ratings for Loblaw Companies Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
13 stock analysts on Stockchase covered Loblaw Companies Ltd In the last year. It is a trending stock that is worth watching.
On 2025-04-01, Loblaw Companies Ltd (L-T) stock closed at a price of $203.46.
The ultimate winner in inflation. Tough business, low margins, competitive. He owns COST. Loblaw is well run, as are MRU and EMP.A